DMRA — Damora Therapeutics Share News
0.000.00%
Last trade - 00:00Galecto Inc expected to post a loss of $2.97 a share - Earnings Preview
Galecto Inc expected to post a loss of $2.97 a share - Earnings Preview
Galecto Inc expected to post a loss of $2.97 a share - Earnings Preview
Galecto Inc expected to post a loss of $2.97 a share - Earnings Preview
Galecto Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Galecto Board Increased Size To Seven Directors & Appointed Amy Wechsler
Brief: Galecto Completes Strategic Review To Focus On Oncology
Brief: Galecto Announces Reverse Stock Split
Galecto Inc reports results for the quarter ended in June - Earnings Summary
Galecto Inc expected to post a loss of 31 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-ACV Auctions, Asbury Automotive Group, Walmart
U.S. RESEARCH ROUNDUP-Acv Auctions, Asbury Automotive Group, Walmart
Brief: Galecto Announces First Patient Dosed In An Investigator-Initiated Phase 2 Trial Of Gb1211 In Combination With Pembrolizumab
Galecto Inc expected to post a loss of 41 cents a share - Earnings Preview
Galecto Inc reports results for the quarter ended in December - Earnings Summary
Brief: Topline Results From Mylox-1 Trial Show Reduced Fibrosis Of Bone Marrow In Patients With Myelofibrosis
Galecto Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Galecto Inc On September 27, Co Received A Deficiency Letter From Nasdaq
Brief: Galecto Inc Estimates That It Will Incur Approximately $2.8 Mln In Restructuring Charges